Weekly Digest – September 2025 Weekly Digest – September 2025 11 September 2025: ENHERTU Type II variation application validated in the EU for previously treated patients with HER2 positive metastatic solid tumors The EMA has validated a Type II Variation […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id